Naši članovi su imali veoma zapaženo učešće na godišnjem kongresu European Association for Cancer Research (EACR) 2024: Innovative Cancer Science, održanom u Roterdamu od 10-13. juna 2024. godine.

Ivana Pašić iz Instituta za onkologiju i radiologiju Srbije i Milan Beljkaš sa Farmaceutskog fakulteta UB nagrađeni su EACR Travel grant stipendijama za apstrakte:

Deciphering the anticancer activity of Cotinus coggygria extracts and compounds with high selectivity against myelogenous leukemia cells
Strengthening the epigenetic and signaling axis: Dual HDAC/ROCK inhibitors as a new therapeutic strategy in cancer treatment

Dr Miloš Lazarević i Dr Dijana Mitić sa Stomatološkog fakulteta UB prikazali su rezultate projekta IDEJE Fonda za nauku RS: Oral cancer – new approaches in prevention, control and post operative regeneration – an in vitro study (ORCA-PCR) pod rukovodstvom prof. Jelene Milašin:

orca-pcrideas.com
Effect of BET inhibitors on oral squamous cell carcinoma cell line and its CD44 positive subpopulation
Lactobacillus salivarius as an Adjuvant to Antitumor Effect of Paclitaxel on oral squamous cell carcinoma

Dr Ana Đurić iz Instituta za onkologiju i radiologiju Srbije prikazala je rezultate projekta STEPUPIORS Horizon Europe Twinning Project:

Expanding the Landscape of Professional Project Management to Support Cancer Research in Serbia
www.stepupiors.eu

Svi apstrakti su dostupni online u časopisu Molecular Oncology

febs.onlinelibrary.wiley.com

Dr Milena Čavić je u ime Upravnog odbora diskutovala sa predstavnicima EACR-a o organizaciji regionalnog HDIR-MOKAD-SDIR kongresa 2025. godine.

Čestitamo svim kolegama i radujemo se EACR 2025 kongresu u Lisabonu!

2025.eacr.org